Items where Author is "Doig, CL"

Group by: Item Type | No Grouping
Number of items: 23.

Journal article

MATTHEWS, J.J., CREIGHTON, J.V., DONALDSON, J., SWINTON, P.A., KYROU, I., BELLARY, S., IDRIS, I., SANTOS, L., TURNER, M.D., DOIG, C.L., ELLIOTT‐SALE, K.J. and SALE, C., 2025. β-alanine supplementation in adults with overweight and obesity: a randomized controlled feasibility trial. Obesity, 33 (2), pp. 278-288. ISSN 1930-7381

GIFFORD, R.M., O’LEARY, T.J., KNIGHT, R.L., WARDLE, S.L., DOIG, C.L., ANDERSON, R.A., GREEVES, J.P., REYNOLDS, R.M. and WOODS, D.R., 2025. Sex-related hypothalamic-pituitary-gonadal and hypothalamic-pituitary-adrenal axis adaptation during military training. Journal of Applied Physiology, 138 (1), pp. 13-21. ISSN 8750-7587

HEASELGRAVE, S.R., HEISING, S., MORGAN, S.A., CARTHWRIGHT, D.M., SAGMEISTER, M., HARDY, R.S., DOIG, C.L., MORTON, N.M., TSINTZAS, K. and LAVERY, G.G., 2024. Glucocorticoid excess alters metabolic rate and substrate utilisation via 11β-HSD1. Journal of Endocrinology, 263 (2): e240205. ISSN 0022-0795

TAN, A., YOUNIS, A.Z., EVANS, A., CREIGHTON, J.V., COVENEY, C., BOOCOCK, D.J., SALE, C., LAVERY, G.G., COUTTS, A.S. and DOIG, C.L., 2023. PARP1 mediated PARylation contributes to myogenic progression and glucocorticoid transcriptional response. Cell Death Discovery, 9: 133. ISSN 2058-7716

YOUNIS, A.Z., LAVERY, G.G., CHRISTIAN, M. and DOIG, C.L., 2023. Rapid isolation of respiring skeletal muscle mitochondria using nitrogen cavitation. Frontiers in Physiology, 14: 1114595. ISSN 1664-042X

CREIGHTON, J.V., DE SOUZA GONÇALVES, L., ARTIOLI, G.G., TAN, D., ELLIOTT-SALE, K.J., TURNER, M.D., DOIG, C.L. and SALE, C., 2022. Physiological roles of carnosine in myocardial function and health. Advances in Nutrition. ISSN 2156-5376

CARTWRIGHT, D.M., OAKEY, L.A., FLETCHER, R.S., DOIG, C.L., HEISING, S., LARNER, D.P., NASTESKA, D., BERRY, C.E., HEASELGRAVE, S.R., LUDWIG, C., HODSON, D.J., LAVERY, G.G. and GARTEN, A., 2021. Nicotinamide riboside has minimal impact on energy metabolism in mouse models of mild obesity. Journal of Endocrinology, 251 (1), pp. 111-123. ISSN 0022-0795

LAVILLA, C.J., BILLACURA, M.P., HANNA, K., BOOCOCK, D.J., COVENEY, C., MILES, A.K., FOULDS, G.A., MURPHY, A., TAN, A., JACKISCH, L., SAYERS, S.R., CATON, P.W., DOIG, C.L., MCTERNAN, P.G., COLOMBO, S.L., SALE, C. and TURNER, M.D., 2021. Carnosine protects stimulus-secretion coupling through prevention of protein carbonyl adduction events in cells under metabolic stress. Free Radical Biology and Medicine. ISSN 0891-5849

OAKEY, L.A., FLETCHER, R.S., ELHASSAN, Y.S., CARTWRIGHT, D.M., DOIG, C.L., GARTEN, A., THAKKER, A., MADDOCKS, O.D.K., ZHANG, T., TENNANT, D.A., LUDWIG, C. and LAVERY, G.G., 2019. Metabolic tracing reveals novel adaptations to skeletal muscle cell energy production pathways in response to NAD+ depletion [version 1; peer review: 2 approved]. Wellcome Open Research, 3: 147. ISSN 2398-502X

ELHASSAN, Y.S., KLUCKOVA, K., FLETCHER, R.S., SCHMIDT, M.S., GARTEN, A., DOIG, C.L., CARTWRIGHT, D.M., OAKEY, L., BURLEY, C.V., JENKINSON, N., WILSON, M., LUCAS, S.J., AKERMAN, I., SEABRIGHT, A., LAI, Y., TENNANT, D.A., NIGHTINGALE, P., WALLIS, G.A., MANOLOPOULOS, K.N., BRENNER, C., PHILP, A. and LAVERY, G.G., 2019. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Reports, 28 (7), pp. 1717-1728. ISSN 2211-1247

FENTON, C.G., DOIG, C.L., FAREED, S., NAYLOR, A., MORRELL, A.P., ADDISON, O., WEHMEYER, C., BUCKLEY, C.D., COOPER, M.S., LAVERY, G.G., RAZA, K. and HARDY, R.S., 2019. 11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy. Arthritis Research and Therapy, 21: 188. ISSN 1478-6362

CHORTIS, V., TAYLOR, A.E., DOIG, C.L., WALSH, M.D., MEIMARIDOU, E., JENKINSON, C., RODRIGUEZ-BLANCO, G., RONCHI, C.L., JAFRI, A., METHERELL, L.A., HEBENSTREIT, D., DUNN, W.B., ARLT, W. and FOSTER, P.A., 2018. Nicotinamide nucleotide transhydrogenase as a novel treatment target in adrenocortical carcinoma. Endocrinology, 159 (8), pp. 2836-2849. ISSN 0013-7227

FINE, N.H.F., DOIG, C.L., ELHASSAN, Y.S., VIERRA, N.C., MARCHETTI, P., BUGLIANI, M., NANO, R., PIEMONTI, L., RUTTER, G.A., JACOBSON, D.A., LAVERY, G.G. and HODSON, D.J., 2018. Glucocorticoids reprogram β-cell signaling to preserve insulin secretion. Diabetes, 67 (2), pp. 278-290. ISSN 0012-1797

FLETCHER, R.S., RATAJCZAK, J., DOIG, C.L., OAKEY, L.A., CALLINGHAM, R., DA SILVA XAVIER, G., GARTEN, A., ELHASSAN, Y.S., REDPATH, P., MIGAUD, M.E., PHILP, A., BRENNER, C., CANTO, C. and LAVERY, G.G., 2017. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells. Molecular Metabolism, 6 (8), pp. 819-832. ISSN 2212-8778

ZIELINSKA, A.E., FLETCHER, R.S., SHERLOCK, M., DOIG, C.L. and LAVERY, G.G., 2017. Cellular and genetic models of H6PDH and 11β-HSD1 function in skeletal muscle. Cell Biochemistry and Function, 35 (5), pp. 269-277. ISSN 0263-6484

DOIG, C.L., FLETCHER, R.S., MORGAN, S.A., MCCABE, E.L., LARNER, D.P., TOMLINSON, J.W., STEWART, P.M., PHILP, A. and LAVERY, G.G., 2017. 11β-HSD1 modulates the set point of brown adipose tissue response to glucocorticoids in male mice. Endocrinology, 158 (6), pp. 1964-1976. ISSN 0013-7227

DOIG, C.L. and LAVERY, G.G., 2016. PARP inhibitors: staying on target? Cell Chemical Biology, 23 (12), pp. 1442-1443. ISSN 2451-9456

HARDY, R.S., DOIG, C.L., HUSSAIN, Z., O'LEARY, M., MORGAN, S.A., PEARSON, M.J., NAYLOR, A., JONES, S.W., FILER, A., STEWART, P.M., BUCKLEY, C.D., LAVERY, G.G., COOPER, M.S. and RAZA, K., 2016. 11β-Hydroxysteroid dehydrogenase type 1 within muscle protects against the adverse effects of local inflammation. The Journal of Pathology, 240 (4), pp. 472-483. ISSN 0022-3417

LARNER, D.P., MORGAN, S.A., GATHERCOLE, L.L., DOIG, C.L., GUEST, P., WESTON, C., HAZELDINE, J., TOMLINSON, J.W., STEWART, P.M. and LAVERY, G.G., 2016. Male 11β-HSD1 knockout mice fed trans-fats and fructose are not protected from metabolic syndrome or nonalcoholic fatty liver disease. Endocrinology, 157 (9), pp. 3493-3504. ISSN 0013-7227

MORGAN, S.A., HASSAN-SMITH, Z.K., DOIG, C.L., SHERLOCK, M., STEWART, P.M. and LAVERY, G.G., 2016. Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism. Journal of Endocrinology, 229 (3), pp. 277-286. ISSN 0022-0795

THORNE, J.L., MAGUIRE, O., DOIG, C.L., BATTAGLIA, S., FEHR, L., SUCHESTON, L.E., HEINANIEMI, M., O’NEILL, L.P., MCCABE, C.J., TURNER, B.M., CARLBERG, C. and CAMPBELL, M.J., 2011. Epigenetic control of a VDR-governed feed-forward loop that regulates p21 ( waf1/cip1 ) expression and function in non-malignant prostate cells. Nucleic Acids Research, 39 (6), pp. 2045-2056. ISSN 0305-1048

BATTAGLIA, S., MAGUIRE, O., THORNE, J.L., HORNUNG, L.B., DOIG, C.L., LIU, S., SUCHESTON, L.E., BIANCHI, A., KHANIM, F.L., GOMMERSALL, L.M., COULTER, H.S.O., RAKHA, S., GIDDINGS, I., O'NEILL, L.P., COOPER, C.S., MCCABE, C.J., BUNCE, C.M. and CAMPBELL, M.J., 2010. Elevated NCOR1 disrupts PPARα/γ signaling in prostate cancer and forms a targetable epigenetic lesion. Carcinogenesis, 31 (9), pp. 1650-1660. ISSN 0143-3334

Review

TAN, A. and DOIG, C.L., 2021. NAD+ degrading enzymes, evidence for roles during infection. Frontiers in Molecular Biosciences, 8: 697359.

This list was generated on Fri Jan 16 11:11:27 2026 UTC.